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1. Introduction
Tissue engineering is an emerging interdisciplinary field that applies the principles of life
science and engineering to produce engineered tissues for the repair and replacement of
damaged tissues or organs [1]. In tissue engineering, tissue scaffolds play a crucial role. A
tissue scaffold is a three-dimensional (3D) structure made from biological materials and bio‐
materials, which is used to facilitate cell/tissue growth and the transport of nutrients and
wastes while degrading gradually itself. To fabricate such tissue scaffolds, a number of fab‐
rication techniques have been developed and reported in the literature and these techniques
can generally be classified into two categories: conventional and advanced. Conventional
techniques [2], including solvent-casting, particulate-leaching, and freeze drying, can build
scaffolds with interconnected porous structures. However, they offer little capacity to pre‐
cisely control pore size, pore geometry, pore interconnectivity, and spatial distribution of
pores or allow for the construction of internal channels within the scaffolds. Ideally, scaf‐
folds should not only provide a supporting structure but also the chemical, mechanical, and
biological signals required to respond to environmental stimuli. As an alternative to conven‐
tional scaffold fabrication methods, advanced fabrication techniques have recently been de‐
veloped in tissue engineering, such as electrospinning [3], a nanotechnology-based
fabrication technique, and rapid prototyping [4], a class of techniques by which a 3D scaf‐
fold is fabricated by laying down multiple, precisely formed layers in succession. With the
development of such advanced tissue engineering fabrication techniques, the new concept
of "biofabrication" has emerged. Biofabrication is defined as the production of complex liv‐
ing and non-living biological products from raw materials, such as living cells, molecules,
extracellular matrices, and biomaterials. It has the potential to be the manufacturing para‐
digm of the 21st century and makes a significant contribution to the development of tissue
engineering strategies [5].
© 2013 Zhu and Chen; licensee InTech. This is an open access article distributed under the terms of the
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2. Overview of scaffold-fabrication techniques
2.1. Conventional fabrication techniques
Many techniques are available to process synthetic and natural biomaterials into various
scaffolds. These include conventional techniques, such as solvent-casting and particulate-
leaching [6], gas foaming [7], phase separation [8], melt molding [9], and freeze drying [10],
among others. An overview of these different techniques follows.
1. Solvent-casting and particulate-leaching (Figure 1a):
Solvent-casting and particulate-leaching techniques involve using a polymer solution uni‐
formly mixed with salt particles of a specific diameter. The solvent then evaporates leaving
behind a polymer matrix with salt particles embedded throughout. The composite is im‐
mersed in water, where the salt leaches out to produce a porous structure [11]. Highly po‐
rous scaffolds with porosity values up to 93% and average pore diameters up to 500 μm can
be formed using this technique. A disadvantage of this technique is that it can only be used
to produce thin membranes up to 3 mm thick [12].
2. Gas foaming (Figure 1b):
During the gas foaming process, molded biodegradable polymers are pressurized at high
pressures with gas-foaming agents, such as CO2 and nitrogen [13], water [14], or fluoroform
[15], until the polymers are saturated. This results in nucleation and growth of gas bubbles
with sizes ranging between 100 and 500 μm in the polymer. This technique has the advant‐
age of being an organic solvent-free process; the major drawback is that the process may
yield a structure with largely unconnected pores and a non-porous external surface [16].
3. Phase separation (Figure 1c):
During the phase separation process, a polymer solution is quenched and undergoes a liq‐
uid-liquid phase separation to form two phases; a polymer-rich phase and a polymer-poor
phase. The polymer-rich phase solidifies and the polymer poor phase is removed, leaving a
highly porous polymer network [17]. The micro- and macro-structure of the resulting scaf‐
folds are controlled by varying process parameters such as polymer concentration, quench‐
ing temperature, and quenching rate. The process is conducted at low temperatures, which
is beneficial for the incorporation of bioactive molecules in the structure. Using phase sepa‐
ration techniques, nano-scale fibrous structure enables to be formed, which mimics natural
extracellular matrix architecture and provides a better environment for cell attachment and
function [18].
4. Melt molding (Figure 1d):
Melt molding involves filling a mold with polymer powder and a porogen component and
then heating to above the glass-transition temperature of the polymer while applying pres‐
sure to the mixture [19]. During the fabrication process, the raw materials will bind together
to form a scaffold with designed specified external shape. Once the mold is removed, the
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porogen is leached out and the porous scaffold is then dried. Melt-molding with porogen-
leaching is a non-solvent fabrication process that allows independent control of morphology
and shape. Drawbacks include the possibility of residual porogen and high processing tem‐
peratures that preclude the ability to incorporate bioactive molecules.
5. Freeze drying (Figure 1e):
Polymeric porous scaffolds can be prepared by freeze drying. In the freezing stage, the poly‐
mer solution is cooled down to a certain temperature at which all materials are in a frozen state
and the solvent forms ice crystals, forcing the polymer molecules to aggregate into the intersti‐
tial spaces. In the second phase, the solvent is removed by applying a pressure lower than the
equilibrium vapor pressure of the frozen solvent. When the solvent is completely sublimated, a
dry polymer scaffold with an interconnected porous microstructure remains [20, 21]. The po‐
rosity of the scaffolds depends on the concentration of the polymer solution; pore size distribu‐
tion is affected by the freezing temperatures. Apart from fabricating porous scaffolds, this
technique is also used to dry biological samples to protect their bioactivities [22].
Figure 1. Schematic of conventional scaffold fabrication techniques: (a) solvent-casting and particulate-leaching proc‐
ess: A polymer solution is cast into a mold filled with porogen particles, then the solvent is allowed to evaporate and
the porogen is leached out; (b) gas foaming process: Polymer samples are exposed to high pressure allowing satura‐
tion of the gas into the polymer; the subsequent gas pressure reduction causes the nucleation of bubbles; (c) phase
separation process: A thermodynamical instability is established in a homogeneous polymer solution that separates
into a polymer-rich and a polymer-poor phase; (d) melt molding process. A mold filled with polymer powder and po‐
rogen component is heated to above the polymer glass-transition temperature (Tg) and a pressure (P) is applied to the
mixture. The porogen is then leached out, leaving a porous structure; (e) freeze drying process: A polymer solution is
cooled down, leading to the formation of solvent ice crystals. Then the solvent is removed by using a pressure lower
than the equilibrium vapor pressure of the solvent (P° solution), leaving a porous structure. (Modified from [23])
2.2. Advanced biofabrication techniques
1. Electrospinning
Electrospinning is a fabrication technique utilizing electrical charges to draw fine fibers up
to the nanometer scale. The technique was invented by Cooley and Morton in 1902. The fi‐
ber electrospinning can also be traced back to the 1930s [24]. In the past decade, significant
developments in electrospinning have allowed for creation of scaffolds with different mate‐
rials and, hence, this technique has gained a high popularity in tissue engineering research.
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Nanofibrous architectures are known to modulate effects on a wide variety of cell behaviors.
Nanofibrous architectures can positively affect cell binding and spreading compared to mi‐
cropore and microfibrous architectures (Figure 2). Nanofibrous scaffold architectures have
larger surface areas to adsorb proteins than micro-architectures, presenting more binding
sites to cell membrane receptors [25]. The exposure of additional cryptic binding sites may
also be affected by adsorbed proteins. Furthermore, cells growing in a 3D nanofibrous struc‐
tural environment are able to exchange nutrients and utilize receptors throughout their sur‐
face, while cells in flat culture conditions are limited to nutrient exchange on only one side.
Electrospinning techniques have been widely employed to fabricate porous scaffolds with
nanofibrous architectures that can mimic the structure and biological functions of the natu‐
ral extracellular matrix [26]. This technique is able to generate fibers with diameters ranging
from 2 nm to several micrometers using solutions of both natural and synthetic polymers,
with small pore sizes and high surface area to volume ratios. A typical electrospinning setup
includes three parts: a syringe pump containing the polymeric materials, a high voltage
source to generate high electric field for spinning, and a collector to collect the fibers [27]
(Figure 3). During scaffold fabrication, the following electrospinning parameters are very
important with respect to the fiber morphology: polymer solution parameters (viscosity,
molecular weight of polymer, polymer conductivity, surface tension), processing parameters
(applied voltage, distance between tip and collector, flow rate), and environment parame‐
ters (humidity, temperature). Nanofibers with high surface area to volume ratios are most
suitable for tissue engineering applications [28].
Figure 2. Scaffold architecture affects cell binding and spreading. (Modified from [25])
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Figure 3. Schematic of electrospinning apparatus. (Modified from [29])
2. Rapid prototyping
As an alternative to conventional scaffold fabrication methods, a group of techniques based
on rapid prototyping (RP) has recently been introduced within the tissue engineering field.
RP techniques, based on computer assisted design (CAD) and manufacturing (CAM) techni‐
ques, allow for better control of scaffold internal microstructure and external macroshape
compared to conventional fabrication techniques [4, 30]. Three basic RP system types: liq‐
uid-based, solid-based, and powder-based can be selected based on the properties of differ‐
ent scaffold biomaterials. The primary RP processes applied to tissue scaffold fabrication
include stereolithography (SLA) [31], selective laser sintering (SLS) [32], fused deposition
modeling (FDM) [33], three dimensional (3D) printing [34], and 3D plotting [35]. The choice
of materials for the RP techniques includes various polymers, ceramics, and metals. Recent‐
ly, RP techniques have also demonstrated their capacity for embedding living cells [36, 37]
and growth factors [38] into scaffolds during the fabrication process and thus their utility for
creating biomimetic tissue scaffolds.
Biofabrication of Tissue Scaffolds
http://dx.doi.org/10.5772/54125
319
Technology Types Materials Advantages Disadvantages
Tissue
Engineering
Applications
SLA Liquid-based Polymers,
wax or wax
compounds
Good mechanical
strength;
easy to remove support
materials;
easy to achieve small
features
Limited to reactive
resins (mostly toxic)
Bone [39],
Heart valves
[40].
SLS Powder-based Metals,
ceramics,
bulk
polymers
Good mechanical
strength; high accuracy;
broad range of materials
Elevated
temperatures; local
high energy input;
uncontrolled porosity
Bone [41, 42],
Cartilage [43].
FDM Solid-based Some
thermoplastic
polymers/
ceramics
Low costs;
good mechanical
strength;
versatile in lay-down
pattern design
Elevated
temperatures;
small range of bulk
materials
Bone [44],
Adipose [45],
Cartilage [46].
3D printing Powder-based powder of
bulk
polymers;
ceramics
Fast processing;
low costs;
no toxic components;
water used as binder
Material must be in
powder form;
weak bonding
between powder
particles;
rough surface;
trapped powder issue;
might require post-
processing
Bone [47],
3D plotting Liquid-based or
solid-based
Swollen
polymers
(hydrogels);
thermoplastic
polymers;
reactive
resins;
ceramics
Broad range of materials
and conditions;
incorporation of cells and
proteins
Slow processing;
no standard
condition;
time consuming
adjustment to new
materials;
low mechanical
strength
Bone [48],
Cartilage [49].
Table 1. RP techniques for tissue engineering
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3. Applications of biofabrication to tissue engineering
3.1. Biofabrication and architectural design of scaffolds
The  microstructure  of  scaffolds  is  increasingly  believed  to  contribute  significantly  to
the diffusion of  nutrients  and metabolic  wastes,  spatial  organization of  cell  growth and
the development of  specific  biological  functions in  tissues.  A scaffold with high porosi‐
ty  is  desirable  for  the  easy  diffusion  of  nutrients  and  metabolic  wastes  and  is  also
beneficial  for  cell  migration and neo-vascularization.  A high surface  area  to  volume ra‐
tio  favors  cell  attachment  and growth.  The  effect  of  scaffold  pore  size  on  tissue  regen‐
eration  is  also  emphasized  by  experiments  demonstrating  that  (1)  an  optimum  pore
size  of  5  μm is  good for  neo-vascularization;  (2)  5  -  15  μm pores  are  beneficial  for  fi‐
berblast  ingrowth;  (3)  20 -  125 μm pores can affect  the regeneration of  adult  mammali‐
an  skin;  and  (4)  fibrovascular  tissues  require  pores  sizes  greater  than  500  μm  [38,  50].
Advanced  biofabrication  techniques  are  able  to  design  and  precisely  control  the  archi‐
tecture of  scaffolds.  They can build scaffolds with reproducible  morphology and micro‐
structure  that  varies  across  the  scaffold  matrix  to  resemble  natural  tissues  with
complex hierarchical  structures.
Conventional  lyophilization  can  only  form  porous  structures  with  random  orientation.
An improved technique  for  fabricating  scaffolds  with  a  linearly  oriented architecture  is
called  "freeze  casting".  Freeze  casting  facilitates  directional  solidification  of  solutions  or
slurries  [51].  During  freeze  casting,  the  polymer  solution  is  pipetted  into  a  cylindrical
mold  fitted  with  a  copper  bottom  plate  and  secured  onto  the  temperature-controlled
copper  cold  finger  of  the  freeze  casting  system.  The  cold  finger  temperature  is  low‐
ered at  a  constant  cooling rate  to  a  final  temperature,  resulting in the directional  solid‐
ification  of  the  material  dispersion.  When  the  ice  is  sublimated  by  freeze  drying,  the
porous  microstructure  of  the  resulting  scaffold  is  a  negative  template  of  the  ice  crys‐
tals.  Freeze  casting  has  been  used  to  produce  a  wide  range  of  porous,  oriented  scaf‐
folds  from  organic  and  inorganic  materials  [51,  52].  This  technique  is  also  suitable  for
the  fabrication  of  nerve  conduit  scaffolds  with  a  featured  porous  structure  that  may
guide axon growth.
Different scaffold fabrication techniques can be combined to capitalize on their respective
positive features for varying applications. The combination of rapid prototyping with lyo‐
philization, in which the polymer solution is dispensed on substrates with a controllable
temperature and the strands formed are frozen and lyophilized to remove the solvent, is
called "rapid freeze prototyping" technique [53]. This technique has the advantage of fabri‐
cating scaffolds with both sub-millimeter and micrometer sized pores [54] (Figure 4). The
optimized porous scaffolds can accommodate tissue ingrowth at different scales, from cells
to tissues. Scaffolds can also be cold processed so that the polymer can be bio-functionalized
without compromising their function during manufacturing.
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Figure 4. Scaffold fabricated by rapid freeze prototyping: (a) camera image of the scaffold, (b) pore size distribution of
the scaffold, (c) wall thickness distribution of the scaffold, and (d) 3D reconstructed model of the scaffold using micro-
tomography. (Modified from [54])
3.2. Biofabrication and scaffolds with living cells
Biofabrication of living structures with desired functionality has become a hot topic in tissue en‐
gineering in past few years. Conventional cell-seeding methods are inadequate for the develop‐
ment of in vitro  tissue-test systems because they involve random placement of cells and,
therefore, lack the precision necessary for spatial control. Conventional cell-seeding methods
are also a type of 2D cell culture. In contrast, cell cultures in 3D structures allow for a more natu‐
ral cell attachment and focal adhesion in all directions. The most physiologically relevant cell
morphology that can be attained on and in three-dimensional scaffolds will provide the best
structural cues to regulate cell function [55, 56]. Different methods of fabricating 3D scaffolds
with living cells have been developed. One of the methods is to spray living cells into the scaf‐
folds throughout the electrospinning process to produce nanofibrous 3D tissue scaffolds. In this
method, cells are periodically sprayed from a pump-action spray bottle onto the developing
scaffold during the electrospinning process [56]. The cells can be layered throughout the thick‐
ness of the scaffolds, but not incorporated into individual polymer nanofibers.
Living cells also can be directly electrospun, as fine composite threads encapsulating living
cells, using a coaxial needle configuration and a biocompatible polymer [57, 58]. The poly‐
mer nanofibers accommodate the survival and proliferation of the cells. Advanced rapid
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prototyping techniques, such as bioprinting, are more capable of incorporating living cells
into scaffolds than other techniques. Introducing cells at almost any arbitrary density and
precisely into the desired location of a scaffold is possible by means of rapid prototyping.
Hydrogel scaffolds, as delivery vehicles for cells, are suitable for bioprinting processes that
seed living cells while constructing scaffolds with specific geometries [36]. A pneumatic dis‐
penser system is used to bioprint the cell-associated scaffolds using polymer solution, such
as alginate aqueous solutions. The fabrication parameters including pressure and nozzle ve‐
locity can be altered, thus affecting the viability of the cells [59]. Complete biological "scaf‐
fold free" tissue substitutes can also be engineered with specific compositions and shapes,
by exploiting cell-cell adhesion and the ability of cultured cells to grow their own ECM;
such approaches have the advantage of reducing and mediating inflammatory responses to
biomaterials [60]. For this concept, extrusion-based bioprinting is an automated deposition
method that can generate a fully biological construct which is structurally and functionally
close to native tissues. Spherical or cylindrical multicellular units (the bio-ink) are delivered
according to a computer-generated template with the hydrogel (the bio-paper) serving as
the support material. The cells neither invade nor rearrange within the hydrogel, which
keeps its integrity during post-printing fusion and can be easily removed to free the fused
multicellular construct (Figure 5). The authentic tissues can be assembled through cell adhe‐
sion, cell sorting, and tissue fusion processes [37].
Figure 5. Scaffold-free bioprinting technology: (a) the bio-printer: 3D printing is achieved by means of a three-axis
positioning system (stage in y and printing heads along x and z (top: Neatco, Carlisle, Canada; bottom: Organovo-In‐
vetech, San Diego)); (b) spheroids with living cells are delivered one by one into the hydrogel bio-paper according to a
computer script; (c) layer-by-layer deposition of cylindrical units of bio-paper (shown in blue) and multicellular cylindri‐
cal building blocks. The outcome of printing (spheroids in panel (b), multicellular cylinders in panel (c)) is a set of dis‐
crete units, which post-printing fuse to form a continuous structure. (Modified from [60])
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4. Summary
Engineered scaffolds are playing an increasingly important role in tissue engineering. Scaf‐
folds should not only have porous structures and provide mechanical support to new tissue
regrowth but also have a complex mimetic hierarchical structure and biological features.
Conventional scaffold fabrication techniques fail to meet these requirements for tissue re‐
generation. Biofabrication technologies have demonstrated potentials in this regard and can
be used to create regenerative tissues or organs through the combination of state of the art
fabrication techniques, materials science, and cell biology.
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